Therapeutic cloning

Lishchyna, V.; Malovana, Nina Volodymyrivna

Please use this identifier to cite or link to this item: https://essuir.sumdu.edu.ua/handle/123456789/78011

Or use following links to share this resource in social networks: Recommend this item

Title	Therapeutic cloning
Authors	Lishchyna, V. Malovana, Nina Volodymyrivna
ORCID	http://orcid.org/0000-0001-5075-1804
Keywords	стовбурові клітини клонування стволовые клетки клонирование stem cells cloning
Type	Conference Papers
Date of Issue	2020
URI	https://essuir.sumdu.edu.ua/handle/123456789/78011
Publisher	Sumy State University
License	Copyright not evaluated
Citation	Lishchyna, V. Therapeutic cloning [Текст] / V. Lishchyna, N.V. Maliovana // To Make the World Smarter and Safer: матеріали XIV всеукраїнської науково-практичної конференції студентів, аспірантів та викладачів Лінгвістичного навчально-методичного центру кафедри іноземних мов СумДУ (26 березня 2020 р.) / за заг. ред. Г.І. Литвиненко. – Суми: СумДУ, 2020. – С. 62-64.
Abstract	The review is devoted to the current biomedical direction in cell-replacement therapy - therapeutic cloning, which is the most universal approach for obtaining patient-specific embryonic stem cell lines (hESC) with tremendous potential in maintaining and restoring human health. Now the main sources of stem cells directly for biomedical work are stem cells from umbilical cord blood and adult stem cells. Both sources have serious limitations: umbilical cord blood stem cells are autogenous only to the newly born, and receiving stem cells from the patient himself is unsafe for him. In addition, in general opinion, the potential for differentiation in these cells is lower than in ESCs. Obviously, the most versatile and reliable source of human stem cell (SC) production is through cloning technology.
Appears in Collections:	Наукові видання (ІФСК)